SEC Form 4 · accession 0001600132-17-000056
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Megan Schoeps
Officer — Principal Financial Officer
Period of report
May 17, 2017
Accepted (ET)
May 19, 2017 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 17, 2017 | F | 10,459 | $1.4039 | D | 18,248 | D |
Table II — derivative securities
No Table II lines on this filing.